| Magaca | Orlistat |
| Lambarka CAS | 96829-58-2 |
| qaacidada molecular | C29H53NO5 |
| Miisaanka molecular | 495.73 |
| Lambarka EINECS | 639-755-1 |
| Meesha dhalaalaysa | <50°C |
| Cufnaanta | 0.976±0.06g/cm3 (La saadaaliyay) |
| Xaaladda kaydinta | 2-8°C |
| Foomka | Budada |
| Midabka | Caddaan |
| Isku-dhafka aysiidhka | (pKa) 14.59±0.23 (La saadaaliyay) |
(S)-2-FORMYLAMINO-4-METHYL-PENTANOICACID(S)-1-[[(2S,3S)-3-HEXYL-4-OXO-2-OXETANYL] METHYL]-DODECYLESTER; RO-18-0647;(-) TETRAHYDROLIPSTAT; ORMYL-L-LEUCINE(1S)-1-[[(2S,3S)-3-HEXYL-4-OXO-2-OXETANYL]METHYL]DODECYLESTER; Orlistat (synthetase/compound); Orlistat (synthesis); Orlistat
Guryaha
Budada crystalline cad, oo ku dhawaad aan lagu milmi karin biyaha, si fudud ugu milmi kara chloroform, aad ugu milmi kara methanol iyo ethanol, si sahlan loo pyrolyze, barta dhalaalidu waa 40 ℃~42 ℃. Unuggiisu waa diastereomer ka kooban afar xarumood oo chiral ah, oo dhererkiisu yahay 529nm, xalkiisa ethanol wuxuu leeyahay wareeg aan fiicneyn.
Habka Waxqabadka
Orlistat waa wax-qabad dheer oo xoog leh oo gaar ah oo xakameynaya lipase-ga dheef-shiid kiimikaadka, kaas oo kicinaya labada enzymes ee kor ku xusan iyadoo la samaynayo dammaanad iskuxiran oo leh goobta serine firfircoon ee lipase ee caloosha iyo mindhicirka yar. Ensaymes aan firfircoonayn uma jebin karaan dufanka cuntada una beddelaan asiidh dufan ah oo bilaash ah iyo Kiimikada glycerol oo uu jidhku nuugi karo, taas oo hoos u dhigaysa qaadashada dufanka iyo dhimista miisaanka. Intaa waxaa dheer, cilmi-baarisyada qaarkood waxay ogaadeen in orlistat ay joojiso nuugista mindhicirka ee kolestaroolka iyadoo la xakameynayo niemann-pick C1-like protein 1 (niemann-pickC1-like1, NPC1L1).
Tilmaamaha
Alaabtan oo ay weheliso cunto yar oo hypocaloric ah waxaa loogu talagalay daawaynta muddada dheer ee shakhsiyaadka cayilan iyo kuwa cayilan, oo ay ku jiraan kuwa leh arrimo halis ah oo la xidhiidha buurnaanta. Alaabtani waxay leedahay xakamaynta miisaanka muddada-dheer (miisaanka luminta, dayactirka miisaanka iyo ka hortagga dib u soo noqoshada) waxtarka. Qaadashada Orlistat waxay hoos u dhigi kartaa arrimaha khatarta ah ee la xidhiidha buurnaanta iyo dhacdooyinka cudurrada kale ee la xidhiidha buurnaanta, oo ay ku jiraan hypercholesterolemia, nooca 2-aad ee sonkorowga, dulqaadka gulukooska ee daciifka ah, hyperinsulinemia, hypertension, iyo yaraynta dufanka xubnaha.
Isdhexgalka Daawooyinka
Waxay yarayn kartaa nuugista fiitamiinada A, D iyo E. Waxaa lagu kabi karaa alaabtan isku mar. Haddii aad qaadanayso diyaargarow ay ku jiraan fiitamiinada A, D iyo E (sida qaar ka mid ah fiitamiinnada badan), waa inaad qaadatid alaabtan 2 saacadood ka dib markaad qaadato alaabtan ama wakhtiga jiifka. Dadka qaba nooca 2-aad ee sonkorowga waxaa laga yaabaa inay u baahdaan inay dhimaan qiyaasta walxaha hypoglycemic ee afka ah (tusaale, sulfonylureas). Wada-shaqeynta cyclosporine waxay keeni kartaa hoos u dhac ku yimaada uruurinta balaasmaha kan dambe. Isticmaalka wadajirka ah ee amiodarone waxay keeni kartaa hoos u dhaca nuugista kan dambe iyo hoos u dhaca waxtarka.